Hecht Beth sold XERS
March 2, 2026 · Form 4 insider transaction
Hecht Beth sold 100 shares of Xeris Biopharma Holdings, Inc. at $7.06 per share, a transaction worth $706.00. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Disposed (sell-side)
Shares
100
Price
$7.06
Total value
$706.00
InsiderHecht Beth
Role—
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateMarch 2, 2026
Filing dateMarch 4, 2026
Shares owned after1,226,507
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
The transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.